637 results on '"Potestio, Luca"'
Search Results
2. Management of Psoriasis Patients with Serious Infectious Diseases
3. Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
4. Very low-calorie ketogenic diet (VLCKD): a therapeutic nutritional tool for acne?
5. Management of Advanced Invasive Melanoma: New Strategies
6. The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
7. Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study
8. The role of teledermatology for the long-term management of stable psoriasis treated with biologics: a survey-based study
9. Unaddressed Challenges in the Treatment of Cutaneous Melanoma?
10. Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study)
11. Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Daungsupawong et al
12. Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study
13. Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation
14. Efficacy and Safety of bimekizumab in psoriasis management in real-life: bio-naïve vs bio-experienced
15. The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials
16. Kaposi's sarcoma as presentation of HIV in an atopic patient treated with upadacitinib
17. New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
18. Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)
19. Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
20. Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
21. Risk Factors for Psoriasis Flares: A Narrative Review
22. Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study
23. The Past, the Present and the Future of Teledermatology: A Narrative Review
24. Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
25. The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials
26. L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter]
27. Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris.
28. Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study
29. Viral reactivation following COVID-19 vaccination: a review of the current literature
30. Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
31. Editorial: New strategies for the treatment of advanced melanoma and non-melanoma skin cancer
32. Considerations for managing elderly patients with atopic dermatitis
33. Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
34. Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
35. Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis
36. The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis
37. Clinical phenotypes of adult atopic dermatitis and related therapies
38. Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond.
39. The impact of body mass index on dupilumab treatment outcomes in adult atopic dermatitis patients.
40. Risk Factors for Psoriasis Flares: A Narrative Review.
41. Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study.
42. Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report.
43. Comment on ‘Development of chilblain lesions during the COVID-19 pandemic is strongly associated with cold weather: a retrospective analysis of patients from a single centre in the USA’
44. A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
45. The Risk of Herpes Virus Infection in Patients With Atopic Dermatitis During Biologic Therapy: A Retrospective Records Based Observational Study
46. Efficacy and Safety of Tralokinumab in Real Life: Possible Predictive Rapid Response Factors
47. An update on the current and emerging pharmacotherapies for basal cell carcinomas
48. Herpes Zoster and COVID-19 Vaccination: A Narrative Review
49. Tralokinumab in elderly atopic dermatitis
50. JAK Inhibitors in Psoriatic Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.